Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases

mesothelioma /

Recently, research on a promising drug for a disease that currently affects 1,500 people in the United States annually was halted due the financial reasons, according to Peter Saltonstall of the National Organization for Rare Diseases. The root of these financial reasons stems from the cost of research versus the expected amount of profits that […]

Improving Adoption Rates of Orphan Drugs for Mesothelioma and Other Rare Diseases Read More »

Environmental Causes Contribute to Lung Cancer More Than Previously Thought

Medical news /

The presence of environmental toxins, such as carcinogens, creates a higher risk for cancer than previously thought, according to a recent report from a presidential cancer panel. In an unrelated 2009 review performed by the American Cancer Society, it was reported that environmental pollutants cause no more than five percent of all cases of cancer.

Environmental Causes Contribute to Lung Cancer More Than Previously Thought Read More »

AACR, FDA and NCI Stress Importance of Biomarkers in Cancer Drug Development

Medical news /

The American Association for Cancer Research (AACR), Food and Drug Administration (FDA) and National Cancer Institute (NCI) joined forces in 2007 to form the Cancer Biomakers Collaboration. According to a recent report filed by the AACR in the journal Clinical Cancer Research, this collaboration seeks “to modernize the drug development process by incorporating new techniques

AACR, FDA and NCI Stress Importance of Biomarkers in Cancer Drug Development Read More »

Face-to-Face Diagnosis Favored by Cancer Patients

cancer treatment, living with mesothelioma /

Reported satisfaction of medical care for cancer patients improves when a diagnosis is provided in person and in a personal setting, according to a recent survey conducted by the National Institutes for Heath (NIH). The survey also suggests that patient satisfaction improves when the doctor takes substantial time to discuss the diagnosis, as well as

Face-to-Face Diagnosis Favored by Cancer Patients Read More »